Spots Global Cancer Trial Database for sintilimab (ibi308)+bevacizumab+oxaliplatin+capecitabine
Every month we try and update this database with for sintilimab (ibi308)+bevacizumab+oxaliplatin+capecitabine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Sintilimab (IBI308) Combined With Bevacizumab + XELOX Regimen in Metastatic Colorectal Cancer | NCT04194359 | Metastatic Colo... RAS Mutation Microsatellite ... | Sintilimab (IBI... | 18 Years - 75 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
